GLAXO WELLCOME EPIVIR AIDS THERAPY REVIEW COMPLETE IN FOUR-AND-A-HALF MONTH ACCELERATED APPROVAL PROCESS; PRODUCT IS FIRST-LINE FOR USE WITH AZT
Executive Summary
Glaxo Wellcome's Epivir (lamivudine, 3TC) will be available in pharmacies the week of Nov. 27, Glaxo said following accelerated approval of the HIV therapy Nov. 17.